Leucine‐Rich Amelogenin Peptide: A Candidate Signaling Molecule During Cementogenesis
Authors:
- Francisco H. NocitiFNFrancisco H. Nociti
- Martha J. SomermanMSMartha J. Somerman
- 1 August 2004
- journal article
- review article
- Published by Wiley in Journal of Periodontology
- Vol. 75 (8) , 1126-1136
Abstract
Background: Cementum is a critical mineralized tissue; however, control of its formation remains undefined. One hypothesis is that enamel matrix proteins/peptides secreted by ameloblasts and/or epithelial rest cells contribute to the control of cementum formation via epithelial‐mesenchymal interactions. Here, we focused on determining whether or not leucine‐rich amelogenin peptide (LRAP), translated from an alternatively spliced amelogenin RNA, altered cementoblast behavior.Methods: Immortalized murine cementoblasts (OCCM‐30) were exposed to LRAP and evaluated for: 1) proliferative activity; 2) gene expression using Northern blot for Cbfa1 (core binding factor alpha‐1); OCN (osteocalcin), OPN (osteopontin), and real‐time reverse transcription‐polymerase chain reaction (RT‐PCR) for OPG (osteoprotegerin); and RANKL (receptor activator of NF‐ κB ligand); 3) signaling pathway using inhibitors of PKA (THFA), PKC (GF109203X), and MAPK (UO126); and 4) mineralization evaluated by von Kossa and Alizarin‐red.Results: LRAP had no effect on cell proliferation up to 6 days, with a decrease in cell growth observed at the highest dose by 9 days versus untreated cells. LRAP down regulated OCN and up regulated OPN in a dose‐ and time‐response fashion, and inhibited the capacity of mineral nodule formation. Transcripts for OPG were increased in LRAP‐treated cells compared to control, but RANKL mRNA levels were not affected. Core binding factor alpha (Cbfa) mRNA, expressed constitutively, was not affected by LRAP. Signaling pathway assays suggested involvement of the MAPK pathway, since the addition of the MAPK inhibitor suppressed OPN expression in LRAP‐treated cells.Conclusion: Leucine‐rich amelogenin peptide appears to have a direct effect on cementoblast activity that may prove significant during development as well as in regeneration of periodontal tissues. J Periodontol 2004;75:1126‐1136.Keywords
This publication has 55 references indexed in Scilit:
- The Receptor Activator of Nuclear Factor-κB Ligand-mediated Osteoclastogenic Pathway Is Elevated in Amelogenin-null MiceJournal of Biological Chemistry, 2003
- A Transgenic Animal Model Resembling Amelogenesis Imperfecta Related to Ameloblastin OverexpressionJournal of Biological Chemistry, 2003
- Presence of an enamel matrix protein derivative on human teeth following periodontal surgeryClinical Oral Investigations, 2002
- Polypeptides Translated From Alternatively Spliced Transcripts of the Amelogenin Gene, Devoid of the Exon 6a,b,c Region, Have Specific Effects on Tooth Germ Development in CultureConnective Tissue Research, 2002
- Model System for Evaluation of Alternative Splicing: Exon SkippingDNA and Cell Biology, 2001
- Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological FunctionsEndocrine Reviews, 2001
- Bone SialoproteinCritical Reviews in Oral Biology & Medicine, 1999
- Immunodetection of Enamel- and Cementum-Related (Bone) Proteins at the Enamel-Free Area and Cervical Portion of the Tooth in Rat MolarsJournal of Bone and Mineral Research, 1997
- Sheathlin: Cloning, cDNA/Polypeptide Sequences, and Immunolocalization of Porcine Enamel Sheath ProteinsJournal of Dental Research, 1997
- Amelin: An enamel-related protein, transcribed in the cells of epithelial root sheathJournal of Bone and Mineral Research, 1996